EQT News and Press, EQT Corporation From 05/05/24

2024-05-05 17:14:23 ET More on the Russell 2000: IWM A Bargain As The S&P 500's P/E Hits 21x It's Selling Season For The Russell 2000 And ETFs That Track It IWM: Are Small Caps Being Overlooked In The Megacap Market Frenzy? Broad market ETFs remain below ...

2024-05-05 08:32:39 ET Summary NextEra Energy is a $144 billion company comprising a significant utility-FPL-and a renewables project division, NEER. The company's dividend is 2.9% currently. NextEra Energy took significant write-offs on its Mountain Valley Pipeline interest in 20...

2024-05-01 09:00:00 ET Summary April 2024 jobs report expected to show an increase of 250,000 jobs, indicating continued tightness in the labor market. Healthcare sector likely to add jobs, while drug manufacturers may struggle. Construction, government, energy, and beverage i...

2024-04-30 09:57:21 ET More on Equitrans Midstream EQT Corp.: Equitrans Deal A Strong Positive Commercially Equitrans Midstream: Long Suffering Is About To End Thanks To EQT Equitrans Midstream Could Be The 'MVP' Of Your Portfolio Read the full article on S...

2024-04-30 08:00:09 ET Mark Lear from Piper Sandler issued a price target of $46.00 for EQT on 2024-04-30 06:57:00. The adjusted price target was set to $46.00. At the time of the announcement, EQT was trading at $41.05. The overall price target consensus is at $41.39 wi...

2024-04-25 10:45:03 ET Astrazeneca plc (AZN) AZN is trading UP for the last 5 days, and it at trading at $74.96 with volume of 5,311,776 and a one day change of $3.76 (5.27%). Astrazeneca plc has a 52-week low of 60.47 and a 52-week high of $76.56. The business's 50-day moving avera...

2024-04-24 20:11:24 ET More on EQT Corp. EQT Corp. Q1 2024 Results - Earnings Call Presentation EQT Corp.: Equitrans Deal A Strong Positive Commercially EQT Looks To Lower Breakeven Costs With Equitrans Deal Read the full article on Seeking Alpha For ...

2024-04-24 17:15:02 ET Wolfe Research analyst issues OUTPERFORM recommendation for EQT on April 24, 2024 03:09PM ET. The previous analyst recommendation was Outperform. EQT was trading at $39.43 at issue of the analyst recommendation. The overall analyst consensus : BUY....

2024-04-24 17:08:12 ET EQT has seen revenue growth driven by gains on derivatives and net marketing services. Operating expenses have increased due to additional capacity and acquisitions. Net income margin has improved but is below industry average. Management implemented cost-cutting me...

2024-04-24 17:00:03 ET Josh Silverstein from Wolfe Research issued a price target of $46.00 for EQT on 2024-04-24 15:09:00. The adjusted price target was set to $46.00. At the time of the announcement, EQT was trading at $39.43. The overall price target consensus is at $...